Biotech at its Best…and how it impacts your future financial and personal health

The organizing committee of the Dutch Business Round Table kindly invites you to our upcoming business lunch, and introduces our next keynote speaker: Harry Welten Board Member Kuros Biosciences and several other biotechs. 

Please confirm your attendance only by email latest by Tuesday 13 March to Pieter van den Bold. Feel free to share this invitation within your business network with any interested party. They are most welcome to join! We are looking forward to meeting you. With best regards, the organizing committee .

About Harry Welten

Spreker Harry Welten - DBRTHarry Welten is a member of the board of several biotech’s as well as from Kuros, such as, Anokion, BiognoSYS, ProteoMediX and Horizon Pharma. He was CFO of Kuros until January 2018 and he served as executive vice president and CFO of Cytos.

He has more than 20 years of international senior executive experience, sixteen of which as chief financial officer in biotech. From 2001 to 2009, he was the CFO at Arpida, which he took public in 2005 at the SIX main segment. Furthermore, he is a member of the foundation council of HBM Foundation. He holds a degree in banking and finance, a degree in economics and business administration and an MBA (Hons.) from Columbia University, NY.

*Cost of the event are to be paid in cash at the entrance. Please be aware that a no-show fee will have to be charged.

van 11.30 tot 14.00
Radisson Blu Hotel, Basel, Steinentorstrasse, Basel, Zwitserland
CHF 60,- voor leden en niet-leden